HALO financial statements

The full income statement, balance sheet, and cash-flow statement for Halozyme Therapeutics Inc. (HALO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 126.7M2024-09 127.2M2024-12 123.2M2025-03 123.2M2025-06 117.0M2025-09 117.6M2025-12 118.0M2026-03 118.6M2026-06 113.5M-10.4% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	1.40B YoY+37.6%	1.02B YoY+22.4%	829M YoY+25.6%	660M YoY+48.9%	443M YoY+65.7%
Cost of revenue	229M YoY+43.5%	159M YoY-17.1%	192M YoY+38.1%	139M YoY+71.1%	81.4M YoY+87.7%
Research & development	81.5M YoY+3.1%	79.0M YoY+3.5%	76.4M YoY+14.6%	66.6M YoY+86.7%	35.7M YoY+4.2%
Selling, general & administrative	207M YoY+34.2%	154M YoY+3.5%	149M YoY+3.9%	144M YoY+185.2%	50.3M YoY+10.0%
Amortization of intangibles	76.7M YoY+7.9%	71.0M YoY-3.7%	73.8M YoY+71.0%	43.1M	0.00
Operating income	469M YoY-15.0%	551M YoY+63.4%	338M YoY+26.2%	268M YoY-3.0%	276M YoY+91.3%
Interest expense	18.1M YoY+0.2%	18.1M YoY-3.6%	18.8M YoY+10.7%	16.9M YoY+125.2%	7.53M YoY-63.1%
Other non-operating income	21.5M YoY-9.6%	23.8M YoY+45.6%	16.3M YoY+1459.9%	1.05M YoY-5.1%	1.10M YoY-79.7%
Pre-tax income	467M YoY-16.2%	557M YoY+59.9%	348M YoY+39.9%	249M YoY+0.2%	249M YoY+92.2%
Income tax	150M YoY+32.7%	113M YoY+69.4%	66.7M YoY+42.6%	46.8M YoY+130.3%	-154M YoY-71156.2%
Net income	317M YoY-28.6%	444M YoY+57.7%	282M YoY+39.3%	202M YoY-49.8%	403M YoY+212.0%
	$2.56 YoY-25.4%	$3.43 YoY+63.3%	$2.10 YoY+45.8%	$1.44 YoY-47.4%	$2.74 YoY+201.1%
EPS (basic)	$2.64 YoY-24.6%	$3.50 YoY+64.3%	$2.13 YoY+43.9%	$1.48 YoY-48.3%	$2.86 YoY+201.1%
	120M YoY-5.5%	127M YoY-3.9%	132M YoY-3.6%	137M YoY-2.7%	141M YoY+3.3%
	124M YoY-4.3%	129M YoY-3.6%	134M YoY-4.6%	141M YoY-4.2%	147M YoY+3.8%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	825M YoY-24.0%	1.09B YoY+45.4%	746M YoY+1.0%	739M YoY-20.2%	926M YoY+67.0%
Cash & equivalents	134M YoY+15.5%	116M YoY-2.1%	118M YoY-49.5%	234M YoY+97.3%	119M YoY-19.6%
Accounts receivable	426M YoY+47.9%	288M YoY+23.6%	233M YoY+24.8%	187M YoY+105.5%	91.0M YoY-6.9%
Inventory	176M YoY+24.4%	142M YoY+11.2%	128M YoY+27.4%	100M YoY+85.7%	53.9M YoY-11.3%
Prepaid expenses	64.6M YoY+65.9%	39.0M YoY-19.9%	48.6M YoY+8.0%	45.0M YoY+11.2%	40.5M YoY+43.2%
	2.53B YoY+22.4%	2.06B YoY+19.1%	1.73B YoY-5.9%	1.84B YoY+66.7%	1.10B YoY+90.4%
Property, plant & equipment	44.4M YoY+8.8%	40.9M YoY+7.2%	38.1M YoY+8.6%	35.1M YoY+416.9%	6.79M YoY-6.9%
Operating lease right-of-use	37.7M YoY+10.3%	34.2M YoY-7.2%	36.8M YoY-9.0%	40.5M YoY+1920.4%	2.00M YoY-39.3%
Goodwill	580M YoY+39.2%	417M YoY+0.0%	417M YoY+1.9%	409M	0.00
Intangible assets	981M YoY+144.2%	402M YoY-15.0%	473M YoY-13.5%	547M	0.00
Deferred tax assets	0.00 YoY-100.0%	3.85M YoY-12.1%	4.39M YoY-90.1%	44.4M YoY-71.4%	155M
	177M YoY+27.3%	139M YoY+23.7%	112M YoY-14.0%	131M YoY+11.6%	117M YoY-72.2%
Accounts payable	20.9M YoY+103.9%	10.2M YoY-13.3%	11.8M YoY-33.2%	17.7M YoY+1048.2%	1.54M YoY-20.1%
Accrued liabilities	156M YoY+21.2%	129M YoY+28.0%	101M YoY+0.9%	99.8M YoY+308.2%	24.4M YoY+19.3%
Deferred revenue	—	—	—	3.25M YoY+85.9%	1.75M YoY+0.0%
Short-term & current debt	0.00	0.00	0.00 YoY-100.0%	13.3M YoY-85.1%	89.4M YoY-77.5%
	2.48B YoY+45.7%	1.70B YoY+3.0%	1.65B YoY-1.3%	1.67B	—
Long-term debt	2.14B YoY+42.3%	1.51B YoY+0.4%	1.50B YoY+0.4%	1.49B YoY+89.6%	787M
Deferred revenue (non-current)	—	—	—	2.25M YoY-10.9%	2.53M YoY-37.2%
Operating lease liability (total)	34.6M YoY+12.6%	30.7M YoY-4.6%	32.2M YoY-7.4%	34.8M YoY+1133.6%	2.82M YoY-42.1%
Deferred tax liabilities	42.9M	0.00	0.00	—	0.00
Other non-current liabilities	114M YoY+107.9%	54.8M YoY+45.2%	37.7M YoY+15.4%	32.7M YoY+5908.5%	544K YoY-84.3%
	48.8M YoY-86.6%	364M YoY+334.1%	83.8M YoY-50.6%	170M YoY-13.8%	197M YoY+30.4%
Preferred stock	0.00	0.00	0.00	0.00	0.00
Common stock	118K YoY-4.1%	123K YoY-3.1%	127K YoY-5.9%	135K YoY-2.2%	138K YoY+2.2%
Additional paid-in capital	12.0M	0.00 YoY-100.0%	2.41M YoY-91.2%	27.4M YoY-89.3%	256M YoY-59.0%
Retained earnings	54.8M YoY-84.8%	360M YoY+297.4%	90.5M YoY-36.8%	143M YoY+343.1%	-58.9M YoY+87.6%
Accumulated other comprehensive income	-18.1M YoY-572.5%	3.83M YoY+141.3%	-9.28M YoY-906.3%	-922K YoY-48.7%	-620K YoY-2918.2%
Total liabilities & equity	2.53B YoY+22.4%	2.06B YoY+19.1%	1.73B YoY-5.9%	1.84B YoY+66.7%	1.10B YoY+90.4%
	118M YoY-4.3%	123M YoY-2.9%	127M YoY-6.2%	135M YoY-1.7%	137M YoY+1.8%
	118M YoY-4.3%	123M YoY-2.9%	127M YoY-6.2%	135M YoY-1.7%	137M YoY+1.8%
	118M YoY-4.2%	123M YoY-2.9%	127M YoY-6.3%	135M YoY-1.7%	138M YoY+1.8%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	652M YoY+36.0%	479M YoY+23.3%	389M YoY+61.8%	240M YoY-19.8%	299M YoY+440.0%
Depreciation & amortization	11.4M YoY+11.0%	10.3M YoY-7.4%	11.1M YoY+70.7%	6.49M YoY+116.6%	3.00M YoY-8.7%
Intangible amortization	76.7M YoY+7.9%	71.0M YoY-3.7%	73.8M YoY+71.0%	43.1M	0.00
Share-based compensation	51.6M YoY+18.9%	43.4M YoY+18.5%	36.6M YoY+50.1%	24.4M YoY+17.2%	20.8M YoY+21.0%
Change in receivables	128M YoY+72.5%	74.2M YoY+2123.6%	3.34M YoY-96.0%	83.9M YoY+1342.6%	-6.75M YoY-117.6%
Change in inventory	-2.55M YoY-103.8%	67.4M YoY+150.6%	26.9M YoY+53.8%	17.5M YoY+337.2%	-7.37M YoY-123.5%
Other operating activities	—	0.00	0.00 YoY+100.0%	-227K YoY-7466.7%	-3.00K YoY+76.9%
	-546M YoY-107.8%	-263M YoY-171.1%	-96.9M YoY+80.1%	-487M YoY-19.9%	-406M YoY-618.5%
Capital expenditure	6.97M YoY-34.8%	10.7M YoY-30.1%	15.3M YoY+218.0%	4.81M YoY+230.1%	1.46M YoY-41.8%
Free cash flow	645M YoY+37.6%	468M YoY+25.5%	373M YoY+58.6%	235M YoY-21.0%	298M YoY+462.8%
Acquisitions	726M	0.00	0.00 YoY-100.0%	999M	0.00
Proceeds from sale of PP&E	—	0.00	0.00 YoY-100.0%	26.0M	0.00 YoY-100.0%
	-85.2M YoY+61.1%	-219M YoY+46.4%	-408M YoY-212.6%	362M YoY+365.4%	77.9M YoY+173.3%
Long-term debt issued	0.00	0.00	0.00	0.00 YoY-100.0%	785M
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00
Common stock issued	0.00	0.00	0.00	0.00	0.00
Common stock repurchased	342M YoY+36.9%	250M YoY-37.9%	402M YoY+101.2%	200M YoY-42.9%	350M YoY+133.2%
Dividends paid	0.00	0.00	0.00	0.00	0.00
Net change in cash	20.6M YoY+916.3%	-2.52M YoY+97.8%	-116M YoY-200.7%	115M YoY+498.4%	-29.0M YoY-205.3%
Interest paid	11.4M YoY+8.2%	10.6M YoY-7.4%	11.4M YoY+86.8%	6.11M YoY+85.3%	3.30M YoY-49.6%
Income taxes paid	135M YoY+67.0%	80.6M YoY+153.9%	31.8M YoY+95.7%	16.2M YoY+4426.4%	-375K YoY-308.3%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	7.94B YoY+34.9%	5.89B YoY+20.6%	4.88B YoY-36.5%	7.69B YoY+38.9%	5.54B YoY-4.2%
P/E	25.1× YoY+89.0%	13.3× YoY-31.0%	19.2× YoY-47.2%	36.4× YoY+164.9%	13.7× YoY-69.3%
P/S	5.7× YoY-1.9%	5.8× YoY-7.3%	6.3× YoY-52.8%	13.3× YoY+6.1%	12.5× YoY-42.2%
P/B	162.7× YoY+905.4%	16.2× YoY-17.4%	19.6× YoY-75.3%	79.3× YoY+182.2%	28.1× YoY-26.5%
P/FCF	12.3× YoY-2.0%	12.6× YoY-8.9%	13.8× YoY-57.4%	32.4× YoY+74.3%	18.6× YoY-83.0%
	4.0% YoY-47.1%	7.5% YoY+45.0%	5.2% YoY+89.4%	2.7% YoY-62.3%	7.3% YoY+225.5%
	8.1% YoY+2.0%	8.0% YoY+9.8%	7.2% YoY+134.6%	3.1% YoY-42.6%	5.4% YoY+487.2%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: HALO's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HALO filings on SEC EDGAR → Not investment advice.